Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Psychophysiology. 2019 Apr 25;56(8):e13385. doi: 10.1111/psyp.13385

TABLE 1.

Demographic and clinical characteristics

MDD (n = 65) Controls (n = 77) Overall (n = 142)
Characteristics
 Gender, male, n (%) 12 (18.5%) 24 (31.2%) 36 (25.4%)
 Age (years) 20.7 (2.6) 20.8 (2.5) 20.8 (2.6)
 BMI (kg/m2) 23.1 (3.5) 23.5 (4.2) 23.3 (3.9)
 VO2peak (mL*kg−1*min−1) 36.9 (7.0) 38.7 (8.7) 37.9 (8.0)
 BDI-II scorec 24.1 (8.6) 8.8 (7.1) 15.8 (10.9)
 BAI scorec 13.4 (8.2) 7.5 (7.3) 10.3 (8.2)
 Comorbidities, n (%)# 16 (24.6%)
Autonomic measures
 HR (bpm)b 78.1 (10.2) 72.5 (8.7) 75.0 (9.8)
 RSA (ms2)a 6.2 (1.0) 6.5 (0.8) 6.4 (1.0)
 PEP (ms) 133.1 (13.3) 137.8 (21.0) 135.7 (18.0)
 CABb −0.3 (1.2) 0.3 (1.4) 0.0 (1.3)
 CAR −0.1 (1.4) 0.0 (1.6) 0.0 (1.5)
 LF/HF 2.6 (2.6) 2.3 (1.7) 2.4 (2.1)
 -zPEP/zRSA 0.8 (10.0) −1.5 (11.8) −0.4 (10.9)
Respiratory parameters
 Respiratory rate (cycles/min) 16.5 (3.5) 15.7 (3.4) 16.1 (3.5)
 Respiratory depth 0.04 (0.07) 0.03 (0.07) 0.04 (0.07)

Note. Values are mean (SD), unless otherwise indicated.

Abbreviations: BAI, Beck Anxiety Inventory; BDI-II, Beck Depression Inventory, 2nd ed.; BMI, body mass index; CAB, cardiac autonomic balance; CAR, cardiac autonomic regulation; HR, heart rate; LF/HF, low frequency/high frequency ratio; MDD, major depressive disorder; PEP, pre-ejection period; RSA, respiratory sinus arrhythmia; VO2peak, peak oxygen consumption; −zPEP/zRSA, ratio of the inverse normalized pre-ejection period to normalized respiratory sinus arrhythmia; cycles/min, respiratory cycles per minute.

a

p < 0.05

b

p < 0.01

c

p < 0.001.

#

Generalized anxiety disorder (n = 9), substance-related disorders (n = 2), post-traumatic stress disorder (n = 1), panic disorder with agoraphobia (n = 1), social anxiety disorder (n = 1); two participants had two of these comorbidities.